Dopamine replacement remediates risk aversion in Parkinson's disease in a value-independent manner
- 1 September 2019
- journal article
- research article
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 66, 189-194
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- Canadian Institutes of Health Research (MOP-130566)
This publication has 26 references indexed in Scilit:
- Sensitivity and Bias in Decision-Making under Risk: Evaluating the Perception of Reward, Its Probability and ValuePLOS ONE, 2012
- Questionnaire for impulsive‐compulsive disorders in Parkinson's Disease–Rating ScaleMovement Disorders, 2011
- The risky business of dopamine agonists in Parkinson disease and impulse control disorders.Behavioral Neuroscience, 2011
- Risk and learning in impulsive and nonimpulsive patients with Parkinson's diseaseMovement Disorders, 2010
- Dissociation of decision-making under ambiguity and decision-making under risk in patients with Parkinson's disease: A neuropsychological and psychophysiological studyNeuropsychologia, 2009
- Personality, Addiction, Dopamine: Insights from Parkinson's DiseaseNeuron, 2009
- Numeracy, ratio bias, and denominator neglect in judgments of risk and probabilityLearning and Individual Differences, 2008
- The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive ImpairmentJournal of the American Geriatrics Society, 2005
- Decision-making impairments in patients with pathological gamblingPsychiatry Research, 2005
- By Carrot or by Stick: Cognitive Reinforcement Learning in ParkinsonismScience, 2004